{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T13:52:04Z","timestamp":1790085124833,"version":"4.0.1"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,10,1]]},"DOI":"10.1093\/qjmed\/hci112","type":"journal-article","created":{"date-parts":[[2005,8,9]],"date-time":"2005-08-09T00:24:17Z","timestamp":1123547057000},"page":"719-727","source":"Crossref","is-referenced-by-count":111,"title":["Clinical and immunological aspects of HLA class I deficiency"],"prefix":"10.1093","volume":"98","author":[{"given":"J.","family":"Zimmer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Andr\u00e8s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Donato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Hanau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Hentges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"de la Salle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2005,8,8]]},"reference":[{"key":"key\n\t\t\t\t20171013082525_BIB1","doi-asserted-by":"crossref","unstructured":"Gromm\u00e9 M, Neefjes J. Antigen degradation or presentation by MHC class I molecules via classical and non-classical pathways. Mol Immunol2002; 39:181\u2013202.","DOI":"10.1016\/S0161-5890(02)00101-3"},{"key":"key\n\t\t\t\t20171013082525_BIB2","doi-asserted-by":"crossref","unstructured":"Pamer E, Cresswell P. Mechanisms of MHC class I-restricted antigen processing. Annu Rev Immunol1998; 16:323\u201358.","DOI":"10.1146\/annurev.immunol.16.1.323"},{"key":"key\n\t\t\t\t20171013082525_BIB3","doi-asserted-by":"crossref","unstructured":"York IA, Rock KL. Antigen processing and presentation by the class I major histocompatibility complex. Annu Rev Immunol1996; 14:369\u201396.","DOI":"10.1146\/annurev.immunol.14.1.369"},{"key":"key\n\t\t\t\t20171013082525_BIB4","unstructured":"Watts C, Powis S. Pathways of antigen processing and presentation. Rev Immunogenetics1999; 1:60\u201374."},{"key":"key\n\t\t\t\t20171013082525_BIB5","doi-asserted-by":"crossref","unstructured":"Yewdell JW, Norbury CC, Bennink JR. Mechanisms of exogenous antigen presentation by MHC class I molecules in vitro and in vivo: implications for generating CD8+ T cell responses to infectious agents, tumors, transplants, and vaccines. Adv Immunol1999; 73:1\u201377.","DOI":"10.1016\/S0065-2776(08)60785-3"},{"key":"key\n\t\t\t\t20171013082525_BIB6","doi-asserted-by":"crossref","unstructured":"The MHC sequencing consortium. Complete sequence and gene map of a human major histocompatibility complex. Nature1999; 401:921\u20133.","DOI":"10.1038\/44853"},{"key":"key\n\t\t\t\t20171013082525_BIB7","doi-asserted-by":"crossref","unstructured":"Gabathuler R, Reith G, Kolaitis G, et al. Comparison of cell lines deficient in antigen presentation reveals a functional role for TAP-1 alone in antigen processing. J Exp Med1994; 180:1415\u201325.","DOI":"10.1084\/jem.180.4.1415"},{"key":"key\n\t\t\t\t20171013082525_BIB8","doi-asserted-by":"crossref","unstructured":"Yabe T, Kawamura S, Sato M, et al. A subject with a novel type I bare lymphocyte syndrome has tapasin deficiency due to a deletion of 4 exons by Alu-mediated recombination. Blood2002; 100:1496\u20138.","DOI":"10.1182\/blood-2001-12-0252"},{"key":"key\n\t\t\t\t20171013082525_BIB9","unstructured":"De la Salle H, Donato L, Zimmer J, et al. HLA class I deficiencies. In: Ochs HD, Smith CIE, Puck JM, eds. Primary Immunodeficiency Diseases: a molecular and genetic approach. New York, Oxford University Press, 1999:181\u20138."},{"key":"key\n\t\t\t\t20171013082525_BIB10","doi-asserted-by":"crossref","unstructured":"Gadola SD, Moins-Teisserenc HT, Trowsdale J, et al. TAP deficiency syndrome. Clin Exp Immunol2000; 121:173\u20138.","DOI":"10.1046\/j.1365-2249.2000.01264.x"},{"key":"key\n\t\t\t\t20171013082525_BIB11","doi-asserted-by":"crossref","unstructured":"De la Salle H, Hanau D, Fricker D, et al. Homozygous human TAP peptide transporter mutation in HLA class I deficiency. Science1994; 265:237\u201341.","DOI":"10.1126\/science.7517574"},{"key":"key\n\t\t\t\t20171013082525_BIB12","doi-asserted-by":"crossref","unstructured":"Donato L, de la Salle H, Hanau D, et al. Association of HLA class I antigen deficiency related to a TAP2 gene mutation with familial bronchiectasis. J Pediatr1995; 127:895\u2013900.","DOI":"10.1016\/S0022-3476(95)70024-2"},{"key":"key\n\t\t\t\t20171013082525_BIB13","doi-asserted-by":"crossref","unstructured":"Donato L, de la Salle H, Hanau D, et al. D\u00e9ficit en antig\u00e8nes HLA de classe I et bronchiectasies familiales: revue de la litt\u00e9rature avec \u00e9tude clinique et biologique. Rev Fr Allergol1997; 37:127\u201334.","DOI":"10.1016\/S0335-7457(97)80035-4"},{"key":"key\n\t\t\t\t20171013082525_BIB14","doi-asserted-by":"crossref","unstructured":"De la Salle H, Zimmer J, Fricker D, et al. HLA class I deficiencies due to mutations in subunit 1 of the peptide transporter TAP1. J Clin Invest1999; 103:R9\u201313.","DOI":"10.1172\/JCI5687"},{"key":"key\n\t\t\t\t20171013082525_BIB15","doi-asserted-by":"crossref","unstructured":"Furukawa H, Murata S, Yabe T, et al. Splice acceptor site mutation of the transporter associated with antigen processing-1 gene in human bare lymphocyte syndrome. J Clin Invest1999; 103:755\u20138.","DOI":"10.1172\/JCI5335"},{"key":"key\n\t\t\t\t20171013082525_BIB16","doi-asserted-by":"crossref","unstructured":"Maeda H, Hirata R, Chen RF, et al. Defective expression of HLA class I antigens: a case of the bare lymphocyte syndrome without immunodeficiency. Immunogenetics1985; 21:549\u201358.","DOI":"10.1007\/BF00395879"},{"key":"key\n\t\t\t\t20171013082525_BIB17","doi-asserted-by":"crossref","unstructured":"Plebani A, Monafo V, Cattaneo R, et al. Defective expression of HLA class I and CD1a molecules in boy with Marfan-like phenotype and deep skin ulcers. J Am Acad Dermatol1996; 35:814\u201318.","DOI":"10.1016\/S0190-9622(96)90091-2"},{"key":"key\n\t\t\t\t20171013082525_BIB18","doi-asserted-by":"crossref","unstructured":"Moins-Teisserenc HT, Gadola SD, Cella M, et al. Association of a syndrome resembling Wegener's granulomatosis with low surface expression of HLA class I-molecules. Lancet1999; 354:1598\u2013603.","DOI":"10.1016\/S0140-6736(99)04206-3"},{"key":"key\n\t\t\t\t20171013082525_BIB19","doi-asserted-by":"crossref","unstructured":"Teisserenc H, Schmitt W, Blake N, et al. A case of primary immunodeficiency due to a defect of the major histocompatibility gene complex class I processing and presentation pathway. Immunol Lett1997; 57:183\u20137.","DOI":"10.1016\/S0165-2478(97)00072-2"},{"key":"key\n\t\t\t\t20171013082525_BIB20","doi-asserted-by":"crossref","unstructured":"Matamoros N, Mil\u00e0 J, Llano M, et al. Molecular studies and NK cell function of a new case of TAP2 homozygous human deficiency. Clin Exp Immunol2001; 125:274\u201382.","DOI":"10.1046\/j.1365-2249.2001.01595.x"},{"key":"key\n\t\t\t\t20171013082525_BIB21","doi-asserted-by":"crossref","unstructured":"Markel G, Mussafi H, Ling KL, et al. The mechanisms controlling NK cell autoreactivity in TAP2-deficient patients. Blood2004; 103:1770\u20138.","DOI":"10.1182\/blood-2003-06-2114"},{"key":"key\n\t\t\t\t20171013082525_BIB22","doi-asserted-by":"crossref","unstructured":"Sugiyama Y, Maeda H, Okumura K, Takaku F. Progressive sinobronchiectasis associated with the \u2018Bare Lymphocyte Syndrome\u2019 in an adult. Chest1986; 89:398\u2013401.","DOI":"10.1378\/chest.89.3.398"},{"key":"key\n\t\t\t\t20171013082525_BIB23","doi-asserted-by":"crossref","unstructured":"Payne R, Brodsky F, Peterlin BM, Young LM. Bare lymphocytes without immunodeficiency. Hum Immunol1983; 6:219\u201327.","DOI":"10.1016\/0198-8859(83)90095-2"},{"key":"key\n\t\t\t\t20171013082525_BIB24","doi-asserted-by":"crossref","unstructured":"De la Salle H, Saulquin X, Mansour I, et al. Asymptomatic deficiency in the peptide transporter associated to antigen processing. Clin Exp Immunol2002; 128:525\u201331.","DOI":"10.1046\/j.1365-2249.2002.01862.x"},{"key":"key\n\t\t\t\t20171013082525_BIB25","doi-asserted-by":"crossref","unstructured":"Mach B, Steimle V, Martinez-Soria E, Reith W. Regulation of MHC class II genes: lessons from a disease. Annu Rev Immunol1996; 14:301\u201331.","DOI":"10.1146\/annurev.immunol.14.1.301"},{"key":"key\n\t\t\t\t20171013082525_BIB26","doi-asserted-by":"crossref","unstructured":"Gobin SJ, Peijnenburg A, van Eggermond M, et al. The RFX complex is crucial for the constitutive and CIITA-mediated transactivation of MHC class I and \u03b22-microglobulin genes. Immunity1998; 9:531\u201341.","DOI":"10.1016\/S1074-7613(00)80636-6"},{"key":"key\n\t\t\t\t20171013082525_BIB27","doi-asserted-by":"crossref","unstructured":"Furukawa H, Yabe T, Watanabe K, et al. Tolerance of NK and LAK activity for HLA class I-deficient targets in a TAP1-deficient patient (bare lymphocyte syndrome type I). Hum Immunol1999; 60:32\u201340.","DOI":"10.1016\/S0198-8859(98)00097-4"},{"key":"key\n\t\t\t\t20171013082525_BIB28","doi-asserted-by":"crossref","unstructured":"Crespi C, Juli\u00e0 MR, Munoz-Saa I, et al. Skewed inhibitory receptors expression in a TAP2-deficient patient. Immunol Lett2003; 68:149\u201353.","DOI":"10.1016\/S0165-2478(03)00005-1"},{"key":"key\n\t\t\t\t20171013082525_BIB29","doi-asserted-by":"crossref","unstructured":"De la Salle H, Houssaint E, Peyrat MA, et al. Human peptide transporter deficiency. Importance of HLA-B in the presentation of TAP-independent EBV antigens. J Immunol1997; 158:4555\u201363.","DOI":"10.4049\/jimmunol.158.10.4555"},{"key":"key\n\t\t\t\t20171013082525_BIB30","doi-asserted-by":"crossref","unstructured":"Zimmer J, Donato L, Hanau D, et al. Activity and phenotype of natural killer cells in peptide transporter (TAP)-deficient patients (type I bare lymphocyte syndrome). J Exp Med1998; 187:117\u201322.","DOI":"10.1084\/jem.187.1.117"},{"key":"key\n\t\t\t\t20171013082525_BIB31","doi-asserted-by":"crossref","unstructured":"Zimmer J, Donato L, Hanau D, et al. Inefficient protection of human TAP-deficient fibroblasts from autologous NK cell-mediated lysis by cytokines inducing HLA class I expression. Eur J Immunol1999; 29:1286\u201391.","DOI":"10.1002\/(SICI)1521-4141(199904)29:04<1286::AID-IMMU1286>3.0.CO;2-L"},{"key":"key\n\t\t\t\t20171013082525_BIB32","doi-asserted-by":"crossref","unstructured":"Vitale M, Zimmer J, Castriconi R, et al. Analysis of natural killer cells in TAP2-deficient patients: expression of functional triggering receptors and evidence for the presence of inhibitory receptor(s) that prevent lysis of normal autologous cells. Blood2002; 99:1723\u20139.","DOI":"10.1182\/blood.V99.5.1723"},{"key":"key\n\t\t\t\t20171013082525_BIB33","doi-asserted-by":"crossref","unstructured":"Wu MF, Raulet DH. Class I-deficient hemopoietic cells and nonhemopoietic cells dominantly induce unresponsiveness of natural killer cells to class I-deficient bone marrow cell grafts. J Immunol1997; 158:1628\u201333.","DOI":"10.4049\/jimmunol.158.4.1628"},{"key":"key\n\t\t\t\t20171013082525_BIB34","unstructured":"Azuma A, Keicho N, Furukawa H, et al. Prolonged survival of a bare lymphocyte syndrome type I patient with diffuse panbronchiolitis treated with erythromycin. Sarcoidosis Vasc Diffuse Lung Dis2001; 18:312\u201313."},{"key":"key\n\t\t\t\t20171013082525_BIB35","doi-asserted-by":"crossref","unstructured":"Sugihara E, Koyanagi T, Niizeki T, et al. Macrolide antibiotics directly reduce active oxygen generation by neutrophils in human peripheral blood. Kurume Med J2003; 50:9\u201315.","DOI":"10.2739\/kurumemedj.50.9"},{"key":"key\n\t\t\t\t20171013082525_BIB36","doi-asserted-by":"crossref","unstructured":"Keicho N, Kudoh S. Diffuse panbronchiolitis: role of macrolides in therapy. Am J Respir Med2002; 1:119\u201331.","DOI":"10.1007\/BF03256601"},{"key":"key\n\t\t\t\t20171013082525_BIB37","doi-asserted-by":"crossref","unstructured":"Schultz H, Schinke S, Weiss J, et al. BPI-ANCA in transporter associated with antigen presentation (TAP) deficiency: possible role in susceptibility to Gram-negative bacterial infections. Clin Exp Immunol2003; 133:252\u20139.","DOI":"10.1046\/j.1365-2249.2003.02197.x"},{"key":"key\n\t\t\t\t20171013082525_BIB38","doi-asserted-by":"crossref","unstructured":"Raghavan M. Immunodeficiency due to a defective antigen processing: the molecular basis for type 1 bare lymphocyte syndrome. J Clin Invest1999; 103:595\u20136.","DOI":"10.1172\/JCI6455"},{"key":"key\n\t\t\t\t20171013082525_BIB39","doi-asserted-by":"crossref","unstructured":"Campbell DJ, Serwold T, Shastri N. Bacterial proteins can be processed by macrophages in a transporter associated with antigen processing-independent, cysteine protease-dependent manner for presentation by MHC class I molecules. J Immunol2000; 164:168\u201375.","DOI":"10.4049\/jimmunol.164.1.168"},{"key":"key\n\t\t\t\t20171013082525_BIB40","doi-asserted-by":"crossref","unstructured":"De la Calle-Martin O, Hernandez M, Ordi J, et al. Familial CD8 deficiency due to a mutation in the CD8\u03b1 gene. J Clin Invest2001; 108:117\u201323.","DOI":"10.1172\/JCI10993"}],"container-title":["QJM: An International Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/qjmed\/article-pdf\/98\/10\/719\/4542725\/hci112.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,4]],"date-time":"2023-05-04T02:08:18Z","timestamp":1683166098000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/qjmed\/article\/98\/10\/719\/1602496\/Clinical-and-immunological-aspects-of-HLA-class-I"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,8,8]]},"references-count":40,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2005,8,8]]},"published-print":{"date-parts":[[2005,10,1]]}},"URL":"https:\/\/doi.org\/10.1093\/qjmed\/hci112","relation":{},"ISSN":["1460-2393","1460-2725"],"issn-type":[{"value":"1460-2393","type":"electronic"},{"value":"1460-2725","type":"print"}],"subject":[],"published-other":{"date-parts":[[2005,10]]},"published":{"date-parts":[[2005,8,8]]}}}